Not applicableStudy completedNCT00806676
What this trial is testing
Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
Who this might be right for
Chronic Kidney Disease
Johns Hopkins University 67